<div class="container">

<table style="width: 100%;"><tr>
<td>colonIDM</td>
<td style="text-align: right;">R Documentation</td>
</tr></table>
<h2>Chemotherapy for Stage B/C colon cancer.</h2>

<h3>Description</h3>

<p>These are data from one of the first successful trials of adjuvant chemotherapy for colon cancer. Levamisole is a low-toxicity compound previously used to treat worm infestations in animals; 5-FU is a moderately toxic (as these things go) chemotherapy agent. </p>


<h3>Usage</h3>

<pre><code class="language-R">data("colonIDM")</code></pre>


<h3>Format</h3>

<p>A data frame with 929 observations on the following 15 variables.
Below a brief description is given for some of these variables.
</p>

<dl>
<dt>time1</dt>
<dd>
<p>Time to recurrence/censoring/death, whichever occurs first.</p>
</dd>
<dt>event1</dt>
<dd>
<p>Recurrence/censoring indicator (recurrence=1, alive=0).</p>
</dd>
<dt>Stime</dt>
<dd>
<p>Time to censoring/death, whichever occurs first.</p>
</dd>
<dt>event</dt>
<dd>
<p>Death/censoring indicator (death=1, alive=0).</p>
</dd>
<dt>rx</dt>
<dd>
<p>Treatment - Obs(ervation), Lev(amisole), Lev(amisole)+5-FU.</p>
</dd>
<dt>sex</dt>
<dd>
<p>Sex indicator (male=1, female=0).</p>
</dd>
<dt>age</dt>
<dd>
<p>Age in years.</p>
</dd>
<dt>obstruct</dt>
<dd>
<p>Obstruction of colon by tumour.</p>
</dd>
<dt>perfor</dt>
<dd>
<p>Perforation of colon.</p>
</dd>
<dt>adhere</dt>
<dd>
<p>Adherence to nearby organs.</p>
</dd>
<dt>nodes</dt>
<dd>
<p>Number of lymph nodes with detectable cancer.</p>
</dd>
<dt>differ</dt>
<dd>
<p>Differentiation of tumour (1=well, 2=moderate, 3=poor).</p>
</dd>
<dt>extent</dt>
<dd>
<p>Extent of local spread (1=submucosa, 2=muscle, 3=serosa,
4=contiguous structures).</p>
</dd>
<dt>surg</dt>
<dd>
<p>Time from surgery to registration (0=short, 1=long).</p>
</dd>
<dt>node4</dt>
<dd>
<p>More than 4 positive lymph nodes.</p>
</dd>
</dl>
<h3>Source</h3>

<p>The study is originally described in Laurie (1989).The main report is found in Moertel (1990). This data set is closest to that of the final report in Moertel (1991). A version of the data with less follow-up time was used in the paper by Lin (1994).
</p>


<h3>References</h3>

<p>JA Laurie, CG Moertel, TR Fleming, HS Wieand, JE Leigh, J Rubin, GW McCormack, JB Gerstner, JE Krook and J Malliard. Surgical adjuvant therapy of large-bowel carcinoma: An evaluation of levamisole and the combination of levamisole and fluorouracil: The North Central Cancer Treatment Group and the Mayo Clinic. Journal of Clinical Oncology, 7:1447-1456, 1989.
</p>
<p>DY Lin. Cox regression analysis of multivariate failure time data: the marginal approach. Statistics in Medicine, 13:2233-2247, 1994.
</p>
<p>CG Moertel, TR Fleming, JS MacDonald, DG Haller, JA Laurie, PJ Goodman, JS Ungerleider, WA Emerson, DC Tormey, JH Glick, MH Veeder and JA Maillard. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. New England Journal of Medicine, 332:352-358, 1990.
</p>
<p>CG Moertel, TR Fleming, JS MacDonald, DG Haller, JA Laurie, CM Tangen, JS Ungerleider, WA Emerson, DC Tormey, JH Glick, MH Veeder and JA Maillard. Fluorouracil plus Levamisole as and effective adjuvant therapy after resection of stage II colon carcinoma: a final report. Annals of Internal Medicine, 122:321-326, 1991.
</p>


<h3>Examples</h3>

<pre><code class="language-R">data(colonIDM)
head(colonIDM)
</code></pre>


</div>